메뉴 건너뛰기




Volumn 2, Issue 3, 2002, Pages 217-234

Structure-based inhibitor design targeting HIV-1 integrase

Author keywords

AIDS; Database searching; Docking; HIV; Integrase; Structure based drug design

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTHRAQUINONE DERIVATIVE; ANTIRETROVIRUS AGENT; CAFFEIC ACID PHENETHYL ESTER; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; INTEGRASE; INTEGRASE INHIBITOR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; NSC 115290; NSC 37078; NSC 74489; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS DNA; VIRUS PROTEIN; ZALCITABINE; ZIDOVUDINE;

EID: 0035986699     PISSN: 15680053     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568005023342380     Document Type: Article
Times cited : (46)

References (196)
  • 196
    • 0005541322 scopus 로고    scopus 로고
    • "Antiretroviral Drugs Approved By FDA for HIV"
    • Office of Special Health Issues Food and Drug Administration
    • (2000)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.